Cermak Elizabeth bought MBRX
November 12, 2025 · Form 4 insider transaction
Cermak Elizabeth bought 150,000 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
N/A
Total value
N/A
InsiderCermak Elizabeth
Role—
SecurityStock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after164,668
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were issued in connection with the reporting person's Board of Director service to the Company.; The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.